We recently published a list of Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this ...

Engineering and design software provider PTC (NASDAQ:PTC) in Q1 CY2025, with sales up 5.5% year on year to $636.4 million.

CHF: Confoederatio Helvetica Francs (Swiss francs)CHMP: Committee for Medicinal Products for Human UseDMD: Duchenne Muscular DystrophyEC: European CommissionFDA: U.S. Food and Drug ...

PTC Therapeutics Background Information (This ... and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Fintel is a leading provider of financial data and insights ...

Q1 2025 Earnings Call Transcript May 6, 2025 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $10.04, ...

PTC Inc. PTC reported second-quarter fiscal 2025 non-GAAP earnings per share (EPS) of $1.79, beating the Zacks Consensus Estimate by 29.7%. The company reported non-GAAP EPS of $1.46 in the prior ...

Fintel reports that on May 7, 2025, Citigroup upgraded their outlook for PTC Therapeutics (NasdaqGS:PTCT) from Sell to Neutral. As of May 6, 2025, the average one-year price target for PTC ...

PTC Inc. (PTC) reported $636.37 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 5.5%. EPS of $1.79 for the same period compares to $1.46 a year ago.

WARREN, N.J., May 1, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that on April 25, 2025, the company approved non-statutory stock options to purchase an aggregate ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...